LPL Financial
GH icon

LPL Financial’s Guardant Health GH Stock Holding History

LPL Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51M Sell
48,822
-32,325
-40% -$3.25M ﹤0.01% 2718
2025
Q4 		$8.29M Buy
81,147
+55,746
+219% +$4.99M ﹤0.01% 2087
2025
Q3 		$1.59M Buy
25,401
+140
+0.6% +$7.62K ﹤0.01% 3541
2025
Q2 		$1.31M Buy
25,261
+6,060
+32% +$271K ﹤0.01% 3504
2025
Q1 		$818K Buy
19,201
+2,773
+17% +$120K ﹤0.01% 3729
2024
Q4 		$502K Sell
16,428
-11,422
-41% -$321K ﹤0.01% 4083
2024
Q3 		$639K Buy
27,850
+11,659
+72% +$330K ﹤0.01% 3792
2024
Q2 		$468K Sell
16,191
-2,056
-11% -$47.9K ﹤0.01% 3932
2024
Q1 		$376K Sell
18,247
-41,243
-69% -$884K ﹤0.01% 4022
2023
Q4 		$1.61M Sell
59,490
-4,476
-7% -$117K ﹤0.01% 2621
2023
Q3 		$1.9M Sell
63,966
-2,031
-3% -$71.4K ﹤0.01% 2332
2023
Q2 		$2.36M Buy
65,997
+1,203
+2% +$34.5K ﹤0.01% 2103
2023
Q1 		$1.52M Sell
64,794
-3,275
-5% -$93.5K ﹤0.01% 2386
2022
Q4 		$1.85M Buy
68,069
+5,135
+8% +$235K ﹤0.01% 2129
2022
Q3 		$3.39M Sell
62,934
-3,965
-6% -$204K ﹤0.01% 1632
2022
Q2 		$2.7M Buy
66,899
+1,065
+2% +$52.8K ﹤0.01% 1794
2022
Q1 		$4.36M Sell
65,834
-5,260
-7% -$360K ﹤0.01% 1530
2021
Q4 		$7.11M Sell
71,094
-942
-1% -$97.4K 0.01% 1225
2021
Q3 		$9.01M Buy
72,036
+16,372
+29% +$1.95M 0.01% 1020
2021
Q2 		$6.91M Buy
55,664
+1,751
+3% +$236K 0.01% 1128
2021
Q1 		$8.23M Sell
53,913
-8,211
-13% -$1.24M 0.01% 933
2020
Q4 		$8.01M Buy
62,124
+12,933
+26% +$1.49M 0.01% 855
2020
Q3 		$5.5M Sell
49,191
-193
-0.4% -$17.7K 0.01% 904
2020
Q2 		$4.01M Buy
49,384
+5,664
+13% +$456K 0.01% 989
2020
Q1 		$3.04M Buy
43,720
+20,614
+89% +$1.58M 0.01% 959
2019
Q4 		$1.81M Buy
23,106
+5,499
+31% +$396K ﹤0.01% 1420
2019
Q3 		$1.12M Buy
17,607
+2,506
+17% +$221K ﹤0.01% 1641
2019
Q2 		$1.3M Buy
15,101
+4,245
+39% +$324K ﹤0.01% 1537
2019
Q1 		$833K Buy
+10,856
New +$602K ﹤0.01% 1782

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's GH Position: Q1 2026 in Review

LPL Financial reduced its Guardant Health (GH) stake by 40% in Q1 2026, selling an estimated $3.25M and leaving 48,822 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

LPL Financial first reported a position in GH in Q1 2019 and has held it in 29 quarters since. The position peaked at $9.01M in Q3 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • LPL Financial held 48,822 shares of Guardant Health worth $4.51M as of Q1 2026.
  • LPL Financial sold 32,325 Guardant Health shares in Q1 2026, an estimated $3.25M.
  • Guardant Health made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2718 holding.
  • LPL Financial first reported a position in Guardant Health in Q1 2019 and has held it in 29 quarters since.
  • LPL Financial's Guardant Health position peaked at $9.01M in Q3 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.